Cell Point (India) Limited

NSE: CELLPOINT · Unclassified

₹14.65+3.90%06 Nov 2026

Check figures: unusual half-yearly results in H1 FY23 (₹6.73 cr vs a typical ₹0.21 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about Cell Point (India) Limited — computed from its filings, no language model

Market cap₹27 cr

Current price₹14.65

High / Low₹20 / ₹12

P/E456.2

P/B0.37

Book value₹39.8

ROE0.1%

ROCE4.9%

Debt / equity1.04

Dividend yield—

EPS (TTM)₹0.03

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY25	FY26
Revenue	295.7	321.2	324.7	367.9
EBITDA	18.0	8.7	7.3	10.2
Operating margin	6.1%	2.7%	2.3%	2.8%
Interest	8.5	5.7	5.2	6.5
Depreciation	0.9	1.9	3.2	3.4
Profit before tax	9.9	2.7	2.8	0.9
Tax	3.1	1.0	0.6	0.9
Net profit	6.7	1.7	2.3	0.1
EPS ₹	4.93	0.97	1.21	0.03
Operating cash flow	7.0	-7.2	-0.7	1.2
Capex	0.5	16.9	5.0	26.4
Dividend paid	0.0	0.0	0.1	0.0
Total assets	—	—	138.2	169.1
Equity	—	—	74.2	74.3

Half-yearly performance

last 8 half years · ₹ crore

showing latest 6 of 8 periods

	H1 FY23*	H2 FY23	H1 FY24	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
Revenue	295.7	0.0	157.8	163.5	153.5	171.2	176.9	191.0
Operating profit	18.0	0.0	4.6	4.0	4.6	2.7	4.2	6.0
Operating margin	6.1%	—	2.9%	2.5%	3.0%	1.6%	2.4%	3.1%
Other income	1.3	0.0	1.5	0.1	1.3	0.2	0.3	0.3
Interest	8.5	0.0	3.5	2.3	2.5	2.7	3.0	3.5
Depreciation	0.9	0.0	0.4	1.5	3.1	0.1	1.3	2.1
Profit before tax	9.9	0.0	2.3	0.4	0.3	2.5	0.3	0.7
Tax	3.1	0.0	0.7	0.4	0.1	0.5	0.1	0.8
Net profit	6.7	0.0	1.7	0.0	0.2	2.0	0.2	-0.1
EPS ₹	4.93	0.00	1.03	0.00	0.12	1.09	0.00	-0.06
Revenue YoY	—	—	-46.6%	—	-2.7%	4.7%	15.3%	11.6%
Profit YoY	—	—	-74.9%	—	-87.0%	20300.0%	-13.6%	-106.4%

Returns & margins

trailing-twelve-month, per half year

showing latest 6 of 7 periods

	H2 FY23	H1 FY24	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
ROE	—	—	—	0.3%	3.0%	3.0%	0.1%
ROCE	—	—	—	4.4%	6.7%	5.9%	4.9%
Net margin	2.3%	1.1%	0.5%	0.1%	0.7%	0.6%	0.0%
EBITDA margin	6.1%	2.9%	2.7%	2.7%	2.3%	2.0%	2.8%
Debt / equity	—	—	—	0.73	0.61	0.90	1.04
Interest coverage	2.16	1.67	1.47	1.15	1.55	1.49	1.15
Asset turnover	—	—	—	2.31	2.35	2.14	2.18

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	18.7	18.7	18.7	18.7
Other equity / reserves	53.7	55.6	55.8	55.6
Total equity	72.3	74.2	74.4	74.3
Borrowings	52.9	45.2	66.9	77.1
Current liabilities	62.9	62.4	78.1	63.0
Non-current liabilities	2.0	1.5	10.1	31.8
Total assets	137.2	138.2	162.6	169.1
Property, plant & equipment	32.4	36.5	56.6	56.5
Investments	0.0	0.0	0.0	0.0
Inventories	57.3	63.6	70.3	66.3
Receivables	0.4	1.2	0.9	1.0
Cash & equivalents	3.2	4.0	3.8	3.7

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY25	FY26
Cash from operations	7.0	-7.2	-0.7	1.2
Cash from investing	-0.5	-30.6	2.3	-27.5
Cash from financing	-4.1	39.2	-7.2	25.8
Capex	0.5	16.9	5.0	26.4
Free cash flow	6.5	-24.1	-5.7	-25.2
Dividends paid	0.0	0.0	0.1	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹56.5 cr33%

Inventories

₹66.3 cr39%

Receivables

₹1.0 cr1%

Cash & equivalents

₹3.7 cr2%

Other assets

₹41.6 cr25%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Cell Point (India) Limited	27	14.65	456.2	0.37	0.1%

StoxGud checklist: Bearish setup · 2/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+0.0%

6 months+2.4%

1 year-19.7%

3Y CAGR-33.1%

5Y CAGR—

10Y CAGR—

50-day avg₹15.57

200-day avg₹16.03

RSI (14)45

FAQs

What is the share price of Cell Point (India) Limited?

Cell Point (India) Limited (CELLPOINT) closed at ₹14.65 on NSE on 06 Nov 2026.

What is the market cap of Cell Point (India) Limited?

₹27 crore at the latest close.

What is the P/E ratio of Cell Point (India) Limited?

456.2, on trailing-twelve-month earnings from its filings.

How fast is Cell Point (India) Limited growing?

Cell Point (India) Limited: revenue has compounded at 7.6% a year over three years; net profit at -79.3% a year. Latest-half-year revenue is up 11.6% year on year, profit down 106.4%.

How profitable is Cell Point (India) Limited?

On a trailing-twelve-month basis return on equity is 0.1%, return on capital employed 4.9%, operating margin 2.8%, net margin 0.0%.

How much debt does Cell Point (India) Limited have?

Cell Point (India) Limited is moderately geared: debt to equity is 1.04 with borrowings of ₹77 cr against cash of ₹4 cr (balance sheet of 2026-03-31). Operating profit covers interest 1.1 times.

Financials parsed from Cell Point (India) Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY23, annual from FY23, balance sheet from Sep '24. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.